Cancel

The 30th Annual Update in Primary Care

he purpose of this meeting is to provide attendees with clinically relevant information about the rapidly changing updates and clinical practice guidelines and has been designed to update regional primary care providers on advances in a variety of internal medicine topics with a dual focus on improving their own clinical practice and highlighting the referral expertise of The Medical College of Wisconsin. Each morning opens with a one-hour featured speaker from various MCW clinical departments...
Medical College of Wisconsin School of Pharmacy

Reducing Hospital Readmissions in Heart Failure: Pharmacy’s Pivotal Role

This activity is accredited for pharmacists and pharmacy technicians involved in the management of patients with Heart Failure (HF). Learning Objectives Upon completion of this activity, the participant will be able to: Pharmacists -Describe the high incidence and burden of HF including the risk of hospitalization and the need to meet quality metrics for the reduction of readmissions in HF -Explain the complex pathophysiology and risk factors for HF -Integrate new classes of pharmaco...
Medical Learning Institute

The Synagis Debate: RSV Risk, Revised Recommendations, and Rising Cost

Learning Objectives: Discuss the prevalence of RSV and risk of hospitalization from severe disease across all neonatal and infant populations. Analyze data regarding palivizumab efficacy and cost effectiveness. Review revised 2014 palivizumab recommendations and discuss validity of changes.
Contemporary Forums

Neonatal Abstinence Syndrome: Something Borrowed, Something New: Are There Best Therapies?

Learning Objectives: Demonstrate improved understanding of current limitations of pharmacologic management of neonatal abstinence syndrome. Have an improved knowledge base of current management options for treating neonatal abstinence. Articulate the ethical and moral challenges and dilemmas in caring for mothers and infants exposed to illicit substances.
Contemporary Forums

Medication Therapy Management (MTM) for the Adult Patient with Diabetes

In this multi-layered, knowledge/application/practice-based continuing pharmacy education activity the University of Connecticut and Drug Topics will develop pharmacist competence in MTM and Motivational Interviewing. The activity is designed to expand from knowledge-based activities to practice-based skills by properly scaffolding knowledge, application and practice-based learning opportunities with sound instructional design. The activities will consist of 3 phases designed to build upon...
University of Connecticut School of Pharmacy

Immunization Training for Pharmacists

Practice Based Immunization Training for Pharmacists A 20 hour practice-based continuing education activity for pharmacists who plan to implement a pharmacist-directed immunization program at their practice site or fulfill the requirements to become a pharmacist immunizer. This comprehensive and interactive practice-based continuing pharmacy education certification program is designed to meet various state regulations* for pharmacist immunizers. *This activity meets state requirements...
University of Connecticut School of Pharmacy

Opioid Overdose & Naloxone Rescue Kits

Fatal drug overdoses, due to both illicit and prescription drug use, have become epidemic in the United States (US). The rate exceeds that of deaths from motor vehicle accidents, largely due to the increase in prescription opioid overdoses.1 In 2013, about 16,000 deaths occurred from prescription opioid overdoses, accounting for more than half of all prescription drug overdose deaths.2 Multiple substances (eg, alcohol, benzodiazepines, and other sedating drugs) often contribute to these over...
SIUE School of Pharmacy

Heart failure: Traditional Therapies and Novel Agents

This CPE activity is intended to refresh pharmacists on the current ACCF/AHA guideline recommendations on the use of pharmacotherapy in heart failure and to introduce them to two novel heart failure agents, sacubitril-valsartan and ivabridine. The activity will describe the agents' characteristics and potential role in heart failure therapy.
SIUE School of Pharmacy

A Skeptic's View of Neonatal Medicine: Balancing Science and Art

Learning Objectives: Describe the indications for the use of bicarbonate in the NICU. Discuss the risks and benefits of postnatal steroids for BPD. Describe the limitations of probiotics for the prevention of NEC.
Contemporary Forums

Toolkit for Community Pharmacists to Improve Patients’ Cardiovascular Health

The community pharmacist is positioned to engage patients in conversations about their health. Cardiovascular wellness has become a major focus through the Million Hearts™ Initiative that aims to prevent one million heart attacks and strokes over the next five years. Because of their close proximity to patients, community pharmacists are able to contribute to this initiative by providing screenings and education about blood pressure and cholesterol management, smoking cessation, aspirin an...
University of Maryland School of Pharmacy: CIPS Knowledge Enterprise

Immunization: Update 2015

In this application-based, RECORDED WEBINAR continuing pharmacy education activity, Dr Jennifer Girotto, PharmD, BCBS, will discuss updated immunization information for the 2015-2016 season. The presentation is password protected. Target Audience: Pharmacists who are interested in immunization information and those who are certified as immunizers who require immunization continuing education to maintain their immunization ability Learning objectives: At the conclusion of the acti...
University of Connecticut School of Pharmacy

Risk Management in Anticoagulation

In this knowledge-based continuing pharmacy education activity Dr Michael Smith, PharmD, CACP, BCPS discusses the main issues related to the management of risk when pharmacists are involved in anticoagulation management. Target Audience Pharmacists who are interested in the management of patients on anticoagulation therapy and/or who are interested in starting pharmacy services for patients on anticoagulation therapy. This activity is not accredited for technicians. Learning Objectives ...
University of Connecticut School of Pharmacy

Hypercoagulable States

In this knowledge-based continuing pharmacy education activity Dr Anuja Rizal discusses her experience with starting an anticoagulation clinic. Target Audience Pharmacists who are interested in the management of patients on anticoagulation therapy. This activity is not accredited for technicians. Learning Objectives At the conclusion of the activity, pharmacists will be able to: Describe inherited hypercoagulable states Describe acquired hypercoagulable states Discu...
University of Connecticut School of Pharmacy

Heparin/Low Molecular Weight Heparin and Fondaparinux Pharmacology and Pharmacotherapy

In this knowledge-based continuing pharmacy education activity Dr Mary Jane Mattern, PharmD, CACP discusses the pharmacology and pharmacotherapy of heparin, low molecular weight heparin and fondaparinux. Target Audience Pharmacists who are interested in the management of patients on anticoagulation therapy and/or who are interested in starting pharmacy services for patients on anticoagulation therapy. This activity is not accredited for technicians. Learning Objectives At the conclusi...
University of Connecticut School of Pharmacy

Vitamin K Antagonist Pharmacology, Pharmacotherapy and Pharmacogenomics

In this knowledge-based continuing pharmacy education activity Dr Mary Jane Mattern, PharmD, CACP discusses the pharmacology and pharmacotherapy of heparin, low molecular weight heparin and fondaparinux. Target Audience Target Audience Pharmacists who are interested in the management of patients on anticoagulation therapy and/or who are interested in starting pharmacy services for patients on anticoagulation therapy. This activity is not accredited for technicians. Learning Objectives...
University of Connecticut School of Pharmacy

Laboratory Monitoring Anticoagulation

In this knowledge-based continuing pharmacy education activity Dr Michael Smith, RPh, PharmD, CACP discusses the various laboratory tests for monitoring anticoagulation therapy. Target Audience: Pharmacists who are interested in the management of patients on anticoagulation therapy and/or who are interested in starting pharmacy services for patients on anticoagulation therapy This activity is not accredited for technicians Learning objectives: At the conclusion of the activity,...
University of Connecticut School of Pharmacy

Case Studies in Drug Interactions with Anticoagulation Therapy

In this application-based continuing pharmacy education activity Dr Philip Hritcko, PharmD, CACP discusses the important drug interactions with anticoagulation therapy and discusses cases related to drug interactions. Target Audience Pharmacists who are interested in the management of patients on anticoagulation therapy and/or who are interested in starting pharmacy services for patients on anticoagulation therapy. This activity is not accredited for technicians. Learning Objec...
University of Connecticut School of Pharmacy

Pharmacist Reimbursement for Anticoagulation Services

In this knowledge-based continuing pharmacy education activity Dr Michael Smith, RPh, PharmD, CACP discusses pharmacist reimbursement issues for anticoagulation services. Target Audience Pharmacists who are interested in the management of patients on anticoagulation therapy and/or who are interested in starting pharmacy services for patients on anticoagulation therapy. This activity is not accredited for technicians. Learning Objectives At the conclusion of the activity, pharmacists w...
University of Connecticut School of Pharmacy

Perioperative Management of Warfarin Interruption

In this application-based continuing pharmacy education activity Dr. Victoria Lambert, PharmD, CACP discuss the important aspects of utilizing bridge therapy for patients on long-term anticoagulation. Target Audience Pharmacists who are interested in the management of patients on anticoagulation therapy and/or who are interested in starting pharmacy services for patients on anticoagulation therapy. This activity is not accredited for technicians. Learning Objectives At the...
University of Connecticut School of Pharmacy

New Oral Anticoagulants: Factor IIa and Xa Inhibitors

In this knowledge-based continuing pharmacy education activity Dr Michael Smith, RPh, PharmD, CACP discusses the new oral anticoagulation agents. Target Audience: Pharmacists who are interested in the management of patients on anticoagulation therapy and/or who are interested in starting pharmacy services for patients on anticoagulation therapy This activity is not accredited for technicians Learning objectives: At the conclusion of the activity, pharmacists will be able to: 1. ...
University of Connecticut School of Pharmacy

Available Strategies to Reverse Oral Anticoagulation Medications

In this application-based continuing pharmacy education activity Dr Michael Smith, PharmD, CACP discusses the reversal of oral anticoagulation medications. Target Audience: Pharmacists who are interested in the management of patients on anticoagulation therapy and/or who are interested in starting pharmacy services for patients on anticoagulation therapy This activity is not accredited for technicians Learning objectives: At the conclusion of the activity, pharmacists will be able t...
University of Connecticut School of Pharmacy

Challenging Topics in Anticoagulation

In this application-based continuing pharmacy education activity Dr Michael Smith, PharmD, CACP discusses challenging topics in anticoagulation). Target Audience: Pharmacists who are interested in the management of patients on anticoagulation therapy and/or who are interested in starting pharmacy services for patients on anticoagulation therapy This activity is not accredited for technicians Learning objectives: At the conclusion of the activity, pharmacists will be able to...
University of Connecticut School of Pharmacy

Developing an Anticoagulation Clinic

In this knowledge-based continuing pharmacy education activity Dr Anuja Rizal discusses her experience with starting an anticoagulation clinic. Target Audience Pharmacists who are interested in the management of patients on anticoagulation therapy and/or who are interested in starting pharmacy services for patients on anticoagulation therapy. This activity is not accredited for technicians. Learning Objectives At the conclusion of the activity, pharmacists will be able to: Di...
University of Connecticut School of Pharmacy

Bone Health: Beyond Calcium

Along with an aging society, cases of osteopenia and osteoporosis are on the rise. Due to various reasons, from side-effects of conventional therapy to a greater interest in preventative wellness, practitioners and patients alike are looking for alternatives and complements to conventional drug treatment for healthy bones.
freeCE.com

Comprehensive Sterile Compounding

COMPREHENSIVE STERILE COMPOUNDING is a 3-day, 20-hour practice-based course designed for pharmacists and technicians who are experienced in compounding. Completion of the Fundamental Compounding & Calculations Course is recommended, but not required. Physicians and other health care professionals are welcome to attend. Participants are instructed in the proper technique preparation, and quality control tests for sterile products, such as validation testing, membrane filtration, pyrogen te...
American College of Apothecaries

HIV/HCV Coinfection: A Primer for Pharmacists and Nurses

It is estimated that in the United States approximately 25% of patients infected with HIV are also coinfected with the hepatitis C virus. This percentage increases to 80% in patients with HIV who also inject drugs. Research has shown that HIV accelerates the progression of liver disease in coinfected patients and increases the risk of developing cirrhosis and cirrhosis complications. In the era of direct-acting antivirals the landscape for treating coinfected patients has changed dramatically ...
freeCE.com

The Opioid Crisis: From Misuse to Abuse to Death

Opioid overdoses and deaths have been increasing at an alarming rate. The over-prescribing and misuse of prescription opioids in recent years has led to heroin abuse, overdoses and deaths in numbers never seen before. Contributing to these deaths has been the contamination of heroin with fentanyl, fentanyl analogs, and other synthetic opioids. Abuse-deterrent formulations, prescription drug monitoring programs and "bystander" naloxone availability are some of the strategies being used to attem...
freeCE.com

New Drugs and Drug News in Pain Management and Palliative Care

It is critically important that pharmacists and pharmacy technicians be knowledgeable about new medications and drug delivery systems introduced to the market to treat pain and advanced illness. Patients, families, caregivers and other healthcare professionals turn to pharmacy professionals to provide accurate and timely information about new drug products including indication, adverse effects, drug interactions and directions for use.
freeCE.com

A Pharmacist's Dozen: A Review of the Most Influential Medications of All Time

The average life span has consistently increased over the past decades, or even century, due to huge advances in overall health care, but with particular attention to medicinal breakthroughs. Year after year, more and more medications are developed and marketed to become some of the most famous medications of all time. In this presentation, we will take a step back, and review what can be considered the most influential medications ever. Some medications can be debated as to having either a po...
freeCE.com

Tools for Validating Prescriptions for Controlled Substances

The Florida Board of Pharmacy now requires all pharmacists to complete a 2 hour, board approved continuing education course on the Validation of Prescriptions for Controlled Substances. Pharmacists seeking license renewal in the state of Florida will need this course prior to the September 2017 renewal. This activity will meet these requirements by providing an in depth review of Florida Statute 64B16-27.831, which covers Validation of Prescriptions for Controlled Substances.
freeCE.com

From the Patient’s Lens: Winning Communications for the Most Difficult Encounters

Pharmacy team members with excellent skills in communications stand out! These are usually the team members who are asked to de-escalate situations with customers, as others back slowly away. With the appropriate use of keenly developed skills, magic unfolds! Suddenly, the angry customer is speaking rationally and working through the same situation that caused an explosion with another well-intentioned team member. How is it, then, that the two associates achieve vastly different results when ...
freeCE.com

The Forgotten Organs: Complications with the Kidney - Anemia Management in Chronic Kidney Disease

Chronic kidney disease (CKD) is estimated to affect approximately 10% of the population in the United States. This means that roughly 2 million people are affected by CKD. Numerous complications can develop in these patients, including anemia. Anemia can have a profound effect on a patient’s quality of life and is an important complication to address in this patient population.
freeCE.com

Pharmacovigilance and Biosimilars: Any Special Considerations?

As biosimilar guidance evolves in the United States and these biologics are studied and FDA-approved for use, it will be important for clinicians to understand how biosimilars’ characteristics overlap with, and differ from, other available biologic therapies, so that effective treatment selection and monitoring, and related patient education, can be achieved.
The France Foundation

Compounding for Hormone Replacement Therapy

COMPOUNDING FOR HORMONE REPLACEMENT THERAPY is a 15 hour practice-­based course designed for pharmacists, technicians, marketers, and students who want to learn more about a growing segment for compounding. Physicians and other healthcare professionals are welcome to attend. Using the basic components of compounding, HRT can be the cornerstone of a successful pharmacy with a diversified practice. Participants will gain a comprehensive knowledge of how and why a patient and practitioner shou...
American College of Apothecaries

Can a Biosimilar be used for all the Same Indications Approved for the Reference Biologic—Even if it hasn’t been Tested in all of those Disease States?

As biosimilar guidance evolves in the United States and these biologics are studied and FDA-approved for use, it will be important for clinicians to understand how biosimilars’ characteristics overlap with, and differ from, other available biologic therapies, so that effective treatment selection and monitoring, and related patient education, can be achieved.
The France Foundation

Interchangeability and Biosimilars: What will this Mean for Clinical Practice?

As biosimilar guidance evolves in the United States and these biologics are studied and FDA-approved for use, it will be important for clinicians to understand how biosimilars’ characteristics overlap with, and differ from, other available biologic therapies, so that effective treatment selection and monitoring, and related patient education, can be achieved.
The France Foundation

How Can We Know that a Biosimilar will be as Safe and Effective as the Reference Product?

As biosimilar guidance evolves in the United States and these biologics are studied and FDA-approved for use, it will be important for clinicians to understand how biosimilars’ characteristics overlap with, and differ from, other available biologic therapies, so that effective treatment selection and monitoring, and related patient education, can be achieved.
The France Foundation

Sorting it Out: Biologics, Biosimilars, Small Molecule Drugs, and Generics

As biosimilar guidance evolves in the United States and these biologics are studied and FDA-approved for use, it will be important for clinicians to understand how biosimilars’ characteristics overlap with, and differ from, other available biologic therapies, so that effective treatment selection and monitoring, and related patient education, can be achieved.
The France Foundation

Drift and the Manufacturing of Biologics: What is it and Does it Matter?

As biosimilar guidance evolves in the United States and these biologics are studied and FDA-approved for use, it will be important for clinicians to understand how biosimilars’ characteristics overlap with, and differ from, other available biologic therapies, so that effective treatment selection and monitoring, and related patient education, can be achieved.
The France Foundation

A Pharmacist's Guide to Caring for Patients Undergoing Treatment for Head and Neck Cancer

This learning activity is intended to provide community pharmacists caring for patients with head and neck cancer with a baseline knowledge of immunotherapy agents utilized and their side effects. Participants will also acquire appropriate adverse effect management strategies. Tactics for communicating with patients who may have disease related barriers will also be discussed
freeCE.com

Health Care Providers’ Perspectives on Biosimilars: Based in Fact or Not?

As biosimilar guidance evolves in the United States and these biologics are studied and FDA-approved for use, it will be important for clinicians to understand how biosimilars’ characteristics overlap with, and differ from, other available biologic therapies, so that effective treatment selection and monitoring, and related patient education, can be achieved.
The France Foundation

PRS 104.1: Compliance with Patient Safety Requirements

This course examines the factors that literally set pharmacists and technicians up to fail in most pharmacy practice environments. It considers how practitioners and managers can work together to meet their shared responsibility of reducing the occurrence of pharmacy errors. The class discusses the relatively unseen, but nevertheless important, fact that pharmacists correct many errors made by prescribers and patients; all to the benefit of drug therapy. The class considers how regulatory obje...
freeCE.com

Sterile Compounding: A Practical Approach to Practice in a USP 797 Environment

Despite broader acceptance and adoption of USP 797 techniques and focus on sterile compounding, incidents continue. In this session, the basic elements of aseptic technique are examined, using the shadow of previous incidents to highlight urgency for adherence. In addition, the role of 503B designated facilities are discussed, as regulatory parameters are outlined and reviewed. This session takes a practical approach to specific aseptic techniques that may be directly applied in a variety of s...
freeCE.com

Validation of Prescriptions for Controlled Substances – Home Study

The main goal of this required 2 hours course for licensed Florida pharmacists (RPh) is to discuss procedures to ensure the appropriate handling and documentation of prescriptions for controlled substances. Included are methods the pharmacist may use to verify patient ID, the validity of the prescription, the scope of practice of the prescriber, as well as methods to record the quantity of drug dispensed, emphasizing proper documentation. Proper decision making is paramount to ensuring that pa...
EXCEL Continuing Education

Preventing Medication Errors in Community Pharmacy

This program will provide tools and techniques for community pharmacists to reduce medication errors in their pharmacies. It will discuss how root cause analysis and failure mode and effects analysis can hep prevent future medication errors and improve patient safety. The program will also provide insight into how technology and electronic prescribing can cause medication errors and what community pharmacists can do to help prevent these types of errors. This program meets the requirement for...
freeCE.com

In the Wrong Hands: Preventing Accidental Poisonings in Children

Despite the sustained progress made by the Poison Prevention Packaging Act of 1970, the percentage of childhood deaths attributed to medications continues to increase. Pharmacists, Pharmacy Technicians, and Nurses are in a prime position to provide education and awareness through professional advocacy. This session seeks to define the scope of the problem using analytical data collected from poison control centers in the United States. In addition, recommendations for the appropriate response ...
freeCE.com

ACPE - COPD Part 5: Quality Improvement Programs REPLAY - (for CPS employees only)

Chronic Obstructive Pulmonary Disease - Part 5: Quality Improvement Programs is a continuing pharmacy education (CPE) activity for health-system PHARMACISTS. This knowledge activity is the home-study replay version of a live webinar originally presented to the pharmacy staff of Comprehensive Pharmacy Services on October 15, 2014. It is part 5 in the COPD series. COPD is now the third leading cause of death in the United States. This activity will describe the implementation of quality...
Comprehensive Pharmacy Services Training

PharmEd-Continuing Education Programs for Pharmacists-Cromwell, CT

Earn up to 7 Credits. Each program is individually accredited so you can attend one or all seminars. Continental breakfast, delicious lunch & afternoon refreshments will be served. Meet with industry professionals for product information and networking. Registration - 8:00 am Conference-8:30 am-5:00 pm
American Health Resources Inc.

PRS 103.1: New Drug Approval Process

This class examines the pathways to approval of new drugs, including the full NDA, the 505(b)(2) approval, the ANDA, and the sNDA. The purpose and form of the new drug approval submission is discussed. Postapproval requirements that are implemented as a condition of new drug approval are studied. The class considers the legal and ethical responsibilities of sponsors and investigators who use human subjects in clinical drug trials. This webinar can be taken as a standalone live 1 credit hour l...
freeCE.com

How Sweet It Is! Management of Diabetes: Introduction to Diabetes Mellitus

Pharmacy practitioners need to be able to recognize patients at risk for diabetes mellitus, and how to differentiate between types 1 and 2, because this drives drug therapy decision making.
freeCE.com

YouTube Google+ Pinterest Twitter LinkedIn Facebook SlideShare
RXinsider, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps. RXinsider, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map.